Point72 Hong Kong’s Edwards Lifesciences EW Stock Holding History

Point72 Hong Kong’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,500	Closed	-$372K	–	605
2022 Q3	$372K	Buy	4,500 +2,200	+96%	+$212K	0.01%	852
2022 Q2	$219K	Buy	+2,300	New	+$238K	0.01%	957
2022 Q1	–	Sell	-5,600	Closed	-$725K	–	1992
2021 Q4	$725K	Buy	5,600 +3,600	+180%	+$420K	0.03%	669
2021 Q3	$226K	Buy	+2,000	New	+$228K	0.01%	1147
2021 Q1	–	Sell	-9,300	Closed	-$848K	–	1922
2020 Q4	$848K	Buy	+9,300	New	+$771K	0.04%	543

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return

Point72 Hong Kong's EW Position: Q3 2025 in Review

Point72 Hong Kong sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 62,178 shares — an estimated $4.86M sold.

Point72 Hong Kong first reported a position in EW in Q4 2014 and held it in 24 quarters. The position peaked at $4.86M in Q2 2025. 1,254 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Point72 Hong Kong reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Point72 Hong Kong sold 62,178 Edwards Lifesciences shares in Q3 2025, an estimated $4.86M.
Point72 Hong Kong first reported a position in Edwards Lifesciences in Q4 2014 and held it in 24 quarters.
Point72 Hong Kong's Edwards Lifesciences position peaked at $4.86M in Q2 2025.
1,254 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.